1. 37: Results of a Phase I/II Trial of 5 Fraction Stereotactic Radiosurgery with Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma Multiforme. (September 2016) Authors: Azoulay, Melissa; Fujimoto, Dylann; Modlin, Leslie; Ho, Clement; Gibbs, Iris; Hancock, Steven L.; Li, Gordon; Chang, Steven D.; Adler, John R.; Harsh, Griffith R.; Harraher, Ciara; Nagpal, Seema; Thomas, Reena; Vrecht, Lawrence; Choi, Clara; Soltys, Scott G. Journal: Radiotherapy and oncology Issue: Volume 120(2016)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Diffuse Leptomeningeal Glioneuronal Tumor Without Diffuse Leptomeningeal Involvement: Detailed Molecular and Clinical Characterization. Issue 9 (20th June 2018) Authors: Kang, Jennifer H; Buckley, Anne F; Nagpal, Seema; Fischbein, Nancy; Peters, Katherine B Journal: Journal of neuropathology and experimental neurology Issue: Volume 77:Issue 9(2018) Page Start: 751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes. Issue 8 (31st January 2020) Authors: Azoulay, Melissa; Chang, Steven D; Gibbs, Iris C; Hancock, Steven L; Pollom, Erqi L; Harsh, Griffith R; Adler, John R; Harraher, Ciara; Li, Gordon; Hayden Gephart, Melanie; Nagpal, Seema; Thomas, Reena P; Recht, Lawrence D; Jacobs, Lisa R; Modlin, Leslie A; Wynne, Jacob; Seiger, Kira; Fujimoto, D... Journal: Neuro-oncology Issue: Volume 22:Issue 8(2020) Page Start: 1182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ACTR-59. A PHASE 1 STUDY OF BPM31510 PLUS VITAMIN K IN SUBJECTS WITH HIGH-GRADE GLIOMA THAT HAS RECURRED ON A BEVACIZUMAB-CONTAINING REGIMEN. (11th November 2019) Authors: Recht, Lawrence; Thomas, Reena; Bertrand, Sophie; Yerballa, Priya; Li, Gordon; Iv, Michael; Narain, Niven; Sarangarajan, Rangaprasad; Granger, Elder; Nagpal, Seema Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bevacizumab Improves Quality of Life in Patients with Recurrent Glioblastoma. (18th September 2011) Authors: Nagpal, Seema; Harsh, Griffith; Recht, Lawrence Other Names: Razis Evangelia D. Academic Editor. Journal: Chemotherapy research and practice Issue: Volume 2011(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. BIMG-13. A NOVEL RADIOPHARMACEUTICAL ([18F]DASA-23) TO MONITOR PYRUVATE KINASE M2 INDUCED GLYCOLYTIC REPROGRAMMING IN GLIOBLASTOMA. (25th March 2021) Authors: Beinat, Corinne; Patel, Chirag; Haywood, Tom; Murty, Surya; Naya, Lewis; Hayden-Gephart, Melanie; Khalighi, Mehdi; Massoud, Tarik; Iagaru, Andrei; Davidzon, Guido; Thomas, Reena; Nagpal, Seema; Recht, Lawrence; Gambhir, Sanjiv Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 1 Page Start: i3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Brain Tumor Mutations Detected in Cerebral Spinal Fluid. (6th January 2020) Authors: Pan, Wenying; Gu, Wei; Nagpal, Seema; Gephart, Melanie Hayden; Quake, Stephen R Journal: Clinical chemistry Issue: Volume 61:Number 3(2015) Page Start: 514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cerebral Blood Flow Changes in Glioblastoma Patients Undergoing Bevacizumab Treatment Are Seen in Both Tumor and Normal Brain. Issue 2 (April 2015) Authors: Andre, Jalal B; Nagpal, Seema; Hippe, Daniel S; Ravanpay, Ali C; Schmiedeskamp, Heiko; Bammer, Roland; Palagallo, Gerald J; Recht, Lawrence; Zaharchuk, Greg Journal: Neuroradiology journal Issue: Volume 28:Issue 2(2015:Apr.) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CLRM-09 FIRST-LINE Tumor TREATING FIELDS (200 KHZ) THERAPY FOR NEWLY-DIAGNOSED GLIOBLASTOMA: THE PHASE 3 TRIDENT TRIAL (EF-32). (5th August 2022) Authors: Shi, Wenyin; Kleinberg, Lawrence; Jeyapalan, Suriya A; Goldlust, Samuel A; Nagpal, Seema; Roberge, David; Nishikawa, Ryo; Grossman, Rachel; Glas, Martin Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 1 Page Start: i7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CMET-27. EVALUATION OF DYNAMIN 2 (DNM2) AS A THERAPEUTIC TARGET IN LEPTOMENINGEAL METASTATIC DISEASE. (11th November 2019) Authors: Chernikova, Sophia; Polyak, Dina; Deng, Jiaojiao; Tsau, Sheila; Casey, Kerriann; Johnson, Eli; Bhambhvani, Hriday; Khoeur, Lina; Stanley, Geoff; Tran, Kevin; Connolly, Ian; Joyce, Annie; Li, Yingmei; von Eyben, Rie; Nagpal, Seema; Hayden Gephart, Melanie Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗